Introducing the next generation Mobile Colposcope, the Gynocular 2.0

The Swedish Medtech company Gynius AB, has developed a Mobile Colposcope, for early detection of cervical cancer, regardless of economical setting.They proudly release the second generation Mobile Colposcope, Gynocular 2.0.

- I am very glad to introduce the Gynocular 2.0 to the Women's Health market, says CEO Isaac Shemer, reflecting on feedback from our users, our team sought to improve our system and push the boundaries of how we can deliver gold-standard diagnostics in a compact, high performing format. The increased light intensity and enhanced green-blue filter enhables the health care provider to better differentiate abnormal lesions from normal cervical tissue.

The Gynocular 2.0 is officially launched at the International Colposcopy IFCPC conference in Orlando, Florida.

- The launch of the Gynocular 2.0, demonstrates the commitment of Gynius to incorporate the feedback of the doctors into a unique product, says US distributor Paul Couture from Crimesciences Inc. It truly enables diagnosis of cervical cancer irrespective of practicing in large clinics and hospitals, or a small remote practice. The portability, ease of use, and quality, brings cervical cancer diagnosis closer to the patient.

For more information about the Gynocular 2.0 in the US and Canada, please contact Paul Couture at paul@crimesciences.com,  and for other locations, contact Gynius AB at info@gynocular.com,